financetom
Business
financetom
/
Business
/
US FDA approves Adaptimmune's gene therapy for rare cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Adaptimmune's gene therapy for rare cancer
Aug 2, 2024 6:33 AM

Aug 2 (Reuters) - The U.S. Food and Drug Administration

said on Friday it has approved Adaptimmune's

first-of-its-kind gene therapy to treat adult patients with a

type of advanced synovial sarcoma who have received prior

chemotherapy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Spectris PLC
Form 8.3 - Spectris PLC
Sep 25, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3 - Ricardo PLC
Form 8.3 - Ricardo PLC
Sep 25, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
ING Comments on Euro, Czech Republic's Koruna, Swiss Franc
ING Comments on Euro, Czech Republic's Koruna, Swiss Franc
Sep 25, 2025
06:13 AM EDT, 09/25/2025 (MT Newswires) -- EUR/USD sold off early Wednesday and that looked to be a function of the German Ifo release, said ING. Here, some doubts seem to be emerging as to how quickly fiscal stimulus can be employed and whether it is indeed just creative accounting, wrote the bank in a note. ING is looking for...
Form 8.3 - Just Group PLC
Form 8.3 - Just Group PLC
Sep 25, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved